< Back to latest news & events

Event

Medical Technology Ireland – Galway Racecourse

September 2019

Event date: 26th September 2019

HGF Partners Kieran Killough and Craig Thomson will be discussing preparation for IP Due Diligence at Medical Technology Ireland on 26th September.

Medical Technology Ireland 2019 will bring together leading international medical device experts providing insight on cutting edge topics for medical device manufacturers, R&D and design engineers in the rapidly evolving Irish and global device marketplace. The conference will define present and future medical device trends, investigate, discuss and improve the quality of life for patients worldwide.

Kieran Killough and Craig Thomson are presenting “preparing for IP Due Diligence: Using your IP to get investment” on Wednesday 26th September. They will discuss how chances of investment are optimised if companies can effectively demonstrate to investors that their IP adequately underpins the business plan on which the investment pitch is based. They will address the following:

  • What is IP Due Diligence?
  • What are the mistakes commonly made during this process?
  • How do you ensure that you impress investors?
  • The importance of demonstrating a relevant IP strategy and timeline that integrates well with your business plan, including your clinical development plan.

Latest updates

The FoodTech Series #1 | Multi-parameter claims, examples outside the scope of the claims: when improvement occurs and evidence becomes easier to demonstrate

            The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they ruled on an opposition …

Read article
Event - 23rd - 25th March 2026

HGF are Gold Sponsors of IPBC Europe 2026

HGF are proud sponsors of IPBC Europe 2026, taking place from 23-25 March 2026 at the Pullman Paris Montparnasse. Bringing together patent pioneers, in-house leaders and private practice specialists, IPBC …

Event details
Event - 8th - 11th February 2026

AUTM Meeting 2026

We are attending the AUTM Annual Meeting from 8–11 February, a flagship event bringing together technology transfer professionals from across the globe. AUTM connects innovators, universities, and industry leaders to …

Event details

The Antibody Series #5 | Epitope-defined antibody claims: when “binds to this epitope” becomes a risk of insufficiency

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews decisions made at the EPO; here, they reviewed an appeal in opposition proceedings after the revocation …

Read article

The Antibody Series #4 | pH points in antibody claims: when “same pH ” becomes an addition of matter

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions; in this case, they reviewed a revocation in opposition of a patent relating to …

Read article

The Antibody Series #3 | Antibody code names in claims: why “ACZ885” is not sufficient to define the antibody

The Boards of Appeal of the EPO (BoA) are the appeal body that reviews EPO decisions. In this case, they examined a claim that identified an antibody by an internal …

Read article

The Antibody Series #2 | Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second installment …

Read article
Event - 3rd February 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details